Immune cell therapies that include CAR-T cells represent a breakthrough in the treatment of haematologic malignancies and are promising in numerous medical fields.

The Cellular Immunotherapy Club, created in 2020 and affiliated to the SFI, brings together immunologists studying the fundamental aspects of CAR-T cell biology (e.g. signal transduction) and researchers and clinicians involved in development and immunomonitoring cellular immunotherapies.

The Club is meant to connect researchers and clinicians of the SFI with those of the societies of specialties where immune cell therapies are utilized or being in development stages, mainly haematology and oncology but also transplantation and clinical immunology. This will be achieved through scientific events that will be co-organized by the Club together with those societies.

Its purpose is to promote immune cell therapy as a major development axis in immunology

The first event of the Cellular Immunotherapy Club took place on Wednesday December 8, 2021 during the Annual Congress of the SFI, Cité des Sciences et de l’Industrie, Paris. The three best abstracts selected for an oral presentation were awarded with the ITcell Miltenyi Prize.

Club Events :

Session SFI & CITC : Harnessing immune signalling for inovative cell therapy

7th French International Symposium on CART cells (CAR T Day), September 6th, 7th, 8th, 2023 Lille, France.


Related contents